Lyssikatos Joseph P
Insider CIK 1967150 · ELVN Chief Scientific Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 112,500 | — | $0 | 112,500 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2026-02-12 | 2026-02-17 | 18,750 | — | $0 | 18,750 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-02-06 | 2026-02-10 | 5,000 | $29.04 | $145.2K | 740,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-22 | 5,491 | $26.37 | $144.8K | 759,697 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-22 | 14,509 | $26.90 | $390.3K | 745,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 50,000 | $29.13 | $1.46M | 765,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 41,198 | $24.90 | $1.03M | 815,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 33,802 | $24.92 | $842.3K | 856,386 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 7,500 | $20.13 | $151.0K | 890,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-12-19 | 2025-12-23 | 5,000 | $16.84 | $84.2K | 897,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-21 | 492 | $23.09 | $11.4K | 902,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-21 | 12,008 | $22.30 | $267.8K | 903,180 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-10-20 | 2025-10-22 | 12,500 | $22.08 | $276.0K | 915,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-26 | 2025-09-30 | 4,000 | $20.25 | $81.0K | 927,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-23 | 2025-09-25 | 1,500 | $20.03 | $30.0K | 931,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-19 | 2025-09-23 | 2,130 | $20.02 | $42.6K | 933,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-19 | 2025-09-23 | 4,870 | $19.11 | $93.1K | 935,318 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-08-21 | 2025-08-21 | 7,500 | $20.01 | $150.1K | 940,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-08-19 | 2025-08-21 | 5,000 | $19.62 | $98.1K | 947,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-21 | 2025-07-23 | 576 | $22.90 | $13.2K | 952,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-21 | 2025-07-23 | 11,924 | $22.26 | $265.4K | 953,264 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-20 | 2025-06-24 | 12,500 | $21.40 | $267.5K | 965,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-03 | 2025-06-05 | 7,500 | $20.03 | $150.2K | 977,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-19 | 2025-05-21 | 5,000 | $16.31 | $81.5K | 985,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-02 | 2025-05-05 | 2,470 | $20.01 | $49.4K | 990,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-01 | 2025-05-05 | 5,030 | $20.07 | $101.0K | 992,658 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-04-21 | 2025-04-23 | 4,670 | $16.03 | $74.9K | 998,018 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-04-21 | 2025-04-23 | 330 | $16.72 | $5.5K | 997,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 12,500 | $20.61 | $257.6K | 1,002,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 171,000 | — | $0 | 171,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-22 | 847 | $30.00 | $25.4K | 1,015,188 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-09 | 2024-10-10 | 34,289 | $28.12 | $964.2K | 1,019,624 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-09 | 2024-10-10 | 3,589 | $28.52 | $102.4K | 1,016,035 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-08 | 2024-10-10 | 13,167 | $27.96 | $368.1K | 1,054,013 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-08 | 2024-10-10 | 100 | $28.51 | $2.9K | 1,053,913 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 2,707 | $27.61 | $74.7K | 1,067,180 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-04 | 2024-10-08 | 7,522 | $27.51 | $206.9K | 1,069,887 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 527 | $27.54 | $14.5K | 1,077,409 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-08-29 | 2024-09-03 | 50 | $23.08 | $1.2K | 1,077,936 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-08-29 | 2024-09-03 | 11,950 | $22.48 | $268.6K | 1,077,986 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-31 | 2024-08-02 | 3,099 | $27.56 | $85.4K | 1,089,936 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-29 | 2024-07-31 | 203 | $27.43 | $5.6K | 1,093,035 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-29 | 2024-07-31 | 11,797 | $26.69 | $314.9K | 1,093,238 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-01 | 2024-07-03 | 12,000 | $22.89 | $274.7K | 1,105,035 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-05-29 | 2024-05-31 | 12,000 | — | $0 | 206,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-29 | 2024-05-31 | 2,123 | $22.52 | $47.8K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-05-29 | 2024-05-31 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-29 | 2024-05-31 | 9,877 | $21.56 | $212.9K | 2,123 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-04-29 | 2024-05-01 | 12,000 | — | $0 | 218,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-29 | 2024-05-01 | 10,987 | $17.86 | $196.2K | 1,013 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-29 | 2024-05-01 | 1,013 | $18.48 | $18.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-04-29 | 2024-05-01 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-04-11 | 2024-04-15 | 30,000 | — | $0 | 230,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-04-11 | 2024-04-15 | 30,000 | $1.12 | $33.6K | 30,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 30,000 | $25.04 | $751.2K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-03 | 12,000 | — | $0 | 260,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-04-01 | 2024-04-03 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 2,352 | $17.72 | $41.7K | 9,648 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 9,577 | $18.80 | $180.0K | 71 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 71 | $19.36 | $1.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-04 | 12,000 | — | $0 | 272,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-29 | 2024-03-04 | 1,805 | $17.09 | $30.8K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-02-29 | 2024-03-04 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-29 | 2024-03-04 | 10,195 | $16.30 | $166.2K | 1,805 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 185,000 | — | $0 | 185,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-01-29 | 2024-01-31 | 12,000 | — | $0 | 284,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-01-29 | 2024-01-31 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-29 | 2024-01-31 | 12,000 | $15.85 | $190.2K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-29 | 2024-01-03 | 12,000 | — | $0 | 296,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-29 | 2024-01-03 | 2,849 | $14.78 | $42.1K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-29 | 2024-01-03 | 9,151 | $14.13 | $129.3K | 2,849 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-29 | 2024-01-03 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-22 | 2023-12-26 | 6,546 | — | $0 | 308,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-22 | 2023-12-26 | 6,546 | $1.12 | $7.3K | 6,546 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-22 | 2023-12-26 | 6,546 | $13.07 | $85.6K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-21 | 2023-12-26 | 20 | — | $0 | 315,096 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-21 | 2023-12-26 | 20 | $1.12 | $22 | 20 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-21 | 2023-12-26 | 20 | $13.00 | $260 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-20 | 2023-12-21 | 8,688 | — | $0 | 315,116 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-20 | 2023-12-21 | 8,688 | $13.01 | $113.0K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-20 | 2023-12-21 | 8,688 | $1.12 | $9.7K | 8,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-19 | 2023-12-21 | 200 | — | $0 | 323,804 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-19 | 2023-12-21 | 200 | $13.00 | $2.6K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-19 | 2023-12-21 | 200 | $1.12 | $224 | 200 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-11-03 | 2023-11-06 | 8,546 | — | $0 | 324,004 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-11-03 | 2023-11-06 | 8,546 | $1.12 | $9.6K | 8,546 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-11-03 | 2023-11-06 | 8,546 | $13.08 | $111.8K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-09-29 | 2023-10-03 | 12,000 | — | $0 | 332,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-09-29 | 2023-10-03 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-09-29 | 2023-10-03 | 12,000 | $13.62 | $163.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 206,000 | — | $0 | 206,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 88,531 | — | $0 | 88,531 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 344,550 | — | $0 | 344,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 1,117,035 | — | $0 | 1,117,035 | SEC↗ |